REGENXBIO Inc.
RGNX
$6.72
$0.172.60%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.81% | 8.34% | 12.07% | 3.75% | 6.00% |
| Total Depreciation and Amortization | -6.38% | -3.41% | 3.99% | 19.50% | 34.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.62% | -7.05% | -13.85% | -12.56% | -15.87% |
| Change in Net Operating Assets | 150.82% | 123.28% | -33.17% | 148.75% | -177.89% |
| Cash from Operations | 20.73% | 16.02% | 12.36% | 17.01% | -5.26% |
| Capital Expenditure | 75.54% | 82.64% | 79.93% | 76.81% | 67.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -47.30% | -49.67% | -58.72% | -11.78% | 968.92% |
| Cash from Investing | -45.82% | -47.11% | -56.81% | -0.51% | 1,700.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,527.17% | 1,562.83% | 3,492.74% | 2,917.95% | 80.84% |
| Repurchase of Common Stock | -117.18% | -117.18% | -117.18% | -117.18% | -47.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.06% | -12.66% | -22.45% | -25.78% | -29.20% |
| Cash from Financing | 365.07% | 377.10% | 390.49% | 405.37% | -21.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 136.85% | 105.13% | 78.95% | 135.21% | 74.85% |
